Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome

Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome, also known as Biemond syndrome type 2, is an extremely rare genetic disorder characterized by a combination of intellectual disability, distinctive facial features (dysmorphism), hypogonadism (underdevelopment of the reproductive system), and diabetes mellitus. The condition was originally described by Biemond in 1934 and affects multiple body systems including the central nervous system, endocrine system, and craniofacial structures. Key clinical features include moderate to severe intellectual disability, iris coloboma (a gap in the iris of the eye), obesity, postaxial polydactyly (extra fingers or toes), and hypogonadotropic hypogonadism leading to delayed or absent puberty. Some patients also develop insulin-resistant diabetes mellitus, typically manifesting later in the disease course. The facial dysmorphism may include a broad face and other distinctive but variable features. This syndrome shares some clinical overlap with Bardet-Biedl syndrome and other ciliopathy-related conditions, but is considered a distinct entity. Due to the extreme rarity of this condition, there is no specific targeted therapy available. Management is supportive and multidisciplinary, involving endocrinological treatment for diabetes and hypogonadism (including hormone replacement therapy), educational support for intellectual disability, ophthalmological monitoring, and surgical correction of polydactyly if needed.

Common questions about Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome